Visible Genomics Company
%20.jpg)
Visible Genomics provides a clinically validated age-related macular degeneration (AMD) risk assessment. The company's comprehensive risk assessment provide advanced awareness of disease risk which will empower the patient and healthcare professional to make informed clinical and lifestyle decisions together, help slow or prevent disease, and provide greater access to more patients through affordable, easy, and understandable genetic risk testing.
Total Funding:
$1M
Headquarters:
Hinsdale, Illinois, United States
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
$10M to $50M
Last Funding Type:
Seed
Technology:
P4 Medicine
Founded Date:
1-1
Industry:
Asset Management, Biotechnology, Health Care